Search Clinical Trials
Completed
Health-Related Quality of Life in Patients With Bladder Cancer (External Link)
OBJECTIVES: - To identify aspects of survivorship experience that differ by clinical risk (low risk vs high risk) in patients with non-invasive bladder cancer. - To collect and examine data …
Completed
Quality of Life and Symptom Management in Patients With Bladder Cancer (External Link)
OBJECTIVES: Primary - To identify aspects of health-related quality of life (HRQOL) and symptom management in patients with non-invasive, low- or high-risk bladder cancer. - To obtain feedback on data …
Completed
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR (External Link)
To participate in this study, patients will need to have given informed consent to have a bone marrow transplant. Before receiving the tetanus vaccine, we would like to test the …
Baylor Role:
Collaborator
Completed
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer (External Link)
Purpose—Accumulating evidence supports the existence of breast cancer stem cells (BCSCs), which are characterized by their capacity to self-renew and divide indefinitely, and resistance to conventional therapies. The Notch pathway …
Baylor Role:
Collaborator
Completed
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) (External Link)
Patients have an EBV-positive cancer. We had gotten permission to take blood from patients in the past, which was used to grow T cells in the laboratory. We first grew …
Baylor Role:
Lead Sponsor
Completed
Bladder Cancer Patient-Reported Outcomes (External Link)
The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from …
Baylor Role:
Lead Sponsor
Completed
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting (External Link)
Interviews are conducted over the telephone and require approximately 90 minutes to complete. Men interviewed are compensated for their participation in the study.
Baylor Role:
Lead Sponsor
Completed
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (External Link)
Participation in this protocol will last about 1 year. To participate in this study, the patient will need to have undergone a stem cell transplant. Before the treatment starts, investigators …
Baylor Role:
Lead Sponsor
Completed
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma (External Link)
Induction Phase Overview The induction phase is approximately 15 weeks long. Chemotherapy is generally given every 3 weeks, each 3 week block is called a "cycle". During these 15 weeks …
Baylor Role:
Lead Sponsor
Completed
Screening for Bladder Cancer (External Link)
Reduction of cancer mortality is a stated goal of the National Cancer Institute. Cancer of the bladder is the 4th most commonly diagnosed cancer and 7th leading cause of cancer …
Baylor Role:
Lead Sponsor